Pulmonary Hemodynamic Effects of Dipyridamole Infusion in Patients with Normal and Elevated Pulmonary Artery Systolic Pressure Receiving PB127

Journal of the American Society of Echocardiography

Volumn 19, Issue 8, 2006, Pages 1038-1044

  Main, Michael L ^a   Ehlgen, Alexander ^a,c   Coggins, Tina R ^a   Morris, Becky A ^a   Lanza, Pam ^a   Tremblay, Thomas M ^a,c   Schiller, Nelson B ^a,b   Goldman, Jonathan H ^a,c  

^a SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Point Biomedical Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE; DIPYRIDAMOLE; GLUCOSE; PB 127; UNCLASSIFIED DRUG;

AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; DRUG EFFECT; FEMALE; FLUSHING; HEADACHE; HUMAN; INJECTION SITE PAIN; LUNG ARTERY; LUNG ARTERY PRESSURE; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MALE; NAUSEA; PRESSURE SENSATION; SIDE EFFECT; STATISTICAL SIGNIFICANCE; STOMACH DISCOMFORT; SYSTOLIC BLOOD PRESSURE;

AGED; ARTIFACTS; BLOOD PRESSURE; CONTRAST MEDIA; DIPYRIDAMOLE; DRUG COMBINATIONS; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION, PULMONARY; INFUSIONS, INTRAVENOUS; MALE; PULMONARY ARTERY; PULMONARY CIRCULATION; RISK ASSESSMENT; RISK FACTORS; VASODILATOR AGENTS;

EID: 33746349826     PISSN: 08947317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.echo.2006.03.006     Document Type: Article

References (18)

1. Wei K., Crouse L., Weiss J., Villanueva F., Schiller N.B., Naqvi T.Z., et al. Comparison of usefulness of dipyridamole stress myocardial contrast echocardiography to technetium-99m sestamibi single-photon emission computed tomography for detection of coronary artery disease (PB127 multicenter phase 2 trial results). Am J Cardiol 91 (2003) 1293-1298
2. Grayburn P.A., Erickson J.M., Escobar J., Womack L., and Velasco C.E. Peripheral intravenous myocardial contrast echocardiography using a 2% dodecafluoropentane emulsion. identification of myocardial risk area and infarct size in the canine model of ischemia. J Am Coll Cardiol 26 (1995) 1340-1347
3. The European Agency for the Evaluation of Medicinal Products. Public statement on Sonovue (sulphur hexafluoride). New contraindication in patients with heart disease. Restriction of use to non-cardiac imaging, May 2004. London, UK.
4. Definity [package insert], 2003, Bristol-Myers Squibb Medical Imaging, Inc., N. Billerica, MA, USA.
5. Optison [package insert], 2003, Amersham Health Inc., Princeton, NJ, USA.
6. Yock P.G., and Popp R.L. Noninvasive estimate of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 70 (1984) 657-662
7. Kircher B.J., Himelman R.B., and Schiller N.B. Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol 66 (1990) 493-496
8. Lee R.T., Lord C.P., Plappert T., and Sutton M.J. Prospective Doppler echocardiographic evaluation of pulmonary artery diastolic pressure in the medical intensive care unit. Am J Cardiol 64 (1989) 1366-1370
9. Abbas A.E., Fortuin F.D., Schiller N.B., Appleton C.P., Moreno C.A., and Lester S.J. A simple method for noninvasive estimation of pulmonary vascular resistance. J Am Coll Cardiol 41 (2003) 1021-1027
10. Correas J.M., and Quay S.D. EchoGen emulsion. a new ultrasound contrast agent based on phase shift colloids. Clin Radiol 51 (1996) 11-14
11. Grayburn P.A., Weiss J.L., Hack T.C., Klodas E., Raichlen J.S., Vannan M.A., et al. Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents. J Am Coll Cardiol 32 (1998) 230-236
12. Marchant E., Pichard A., Rodriguez J.A., and Casanegra P. Acute effects of systemic versus intracoronary dipyridamole on coronary circulation. Am J Cardiol 57 (1986) 1401-1404
13. Cortigiani L., Baroni M., Picano E., Palmieri C., Boni A., Ravani M., et al. Acute hemodyanmic effects of endogenous adenosine in patients with chronic heart failure. Am Heart J 136 (1998) 37-42
14. Picano E., Sicari R., and Varga A. Dipyridamole stress echocardiography. Cardiol Clin 17 (1999) 481-499
15. Ranhosky A., Kempthorne-Rawson J., and Intravenous Dipyridamole Thallium Imaging Study Group. The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Circulation 81 (1990) 1205-1209
16. Lette J., Tatum J.L., Fraser S., Miller D.D., Waters D.D., Heller G., et al. Safety of dipyridamole testing in 73806 patients. the multicenter dipyridamole safety study. J Nucl Cardiol 2 (1995) 3-17
17. Picano E., Marini C., Pirelli S., Maffei S., Bolognese L., Chiriatti G., et al. Safety of intravenous high-dose dipyridamole echocardiography. the echo-Persantine international cooperative study group. Am J Cardiol 70 (1992) 252-258
18. Raisinghani A., Wei K.S., Crouse L., Villanueva F., Feigenbaum H., Schiller N.B., et al. Myocardial contrast echocardiography (MCE) with triggered ultrasound does not cause premature ventricular complexes. evidence from PB127 MCE studies. J Am Soc Echocardiogr 16 (2003) 1037-1042